Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

RISK-HUNT3R · RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs

H2020Status: SIGNED1 June 202130 November 2026EU funding €22,927,769Call H2020-SC1-BHC-2018-2020

The vision of the RISK-HUNT3R consortium is to develop a reliable, efficient and cost-effective chemical safety assessment approach. It will be based entirely on non-animal methods and provide improved protection of the human population against systemic health effects caused by (chronic) chemical exposure. The major innovation provided by RISK-HUNT3R is a complete and truly human-centric risk assessment strategy. RISK-HUNT3R will establish, optimize and assemble all essential safety testing elements: exposure assessment, information on chemical distribution in the body, hazard characterization, adverse outcome prediction and determination of actual risk in defined scenarios. RISK-HUNT3R integrates cutting-edge in silico (computational) and in vitro (experimental testing) technologies. Human (disease) genetics and exposome data will ensure anchoring of test results to the human situation. The project will ensure regulatory relevance by testing the applicability of the critical test systems integrated in the next generation risk assessment strategy. The ambitious overall deliverable will be a comprehensive computational framework for the prediction of human adverse outcomes, and a set of stringently evaluated assays to feed the required data into this framework. RISK-HUNT3R will engage with all key stakeholders from different industry sectors and international regulatory agencies to critically evaluate and warrant genuine acceptance of the novel safety testing framework. This unique interaction of these key stakeholders working together on real-world case studies, will result in a ready-to-apply strategy to ensure societal protection against hazardous chemicals fully in concordance with the European Commission’s “Green Deal”. Importantly, the project will push commercial exploitation of the validated safety assessment approaches, thereby ensuring sustainability of the project outcomes and fortifying the innovation capacity of the industry sectors involved.

Consortium · 40 organisations

coordinator

UNIVERSITEIT LEIDEN

NL · €2,916,214

participant

TOXYS B.V.

NL · €259,375

participant

BioDetection Systems B.V.

NL · €582,500

participant

UNIVERSIDAD POMPEU FABRA

ES · €380,000

participant

BUNDESINSTITUT FUER RISIKOBEWERTUNG

DE · €842,363

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €400,000

participant

LUNDS UNIVERSITET

SE · €398,210

participant

STEINBEIS GMBH & CO KG FUR TECHNOLOGIE TRANSFER

DE · €695,000

participant

STICHTING VU

NL · €813,930

participant

NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO

NL · €366,403

participant

EUROPEAN MOLECULAR BIOLOGY LABORATORY

DE · €318,411

participant

CERTARA UK LIMITED

UK · €725,625

participant

UNIVERSITAT WIEN

AT · €696,750

participant

FRAUNHOFER GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG EV

DE · €970,750

participant

EDELWEISS CONNECT GMBH

CH · €939,043

thirdParty

BASF METABOLOME SOLUTIONS GMBH

DE

participant

INDUSTRIA DE DISENO TEXTIL SA

ES · €5,000

participant

COSMETICS EUROPE - THE PERSONAL CARE ASSOCIATION

BE

participant

KOBENHAVNS UNIVERSITET

DK · €400,091

participant

RISE RESEARCH INSTITUTES OF SWEDEN AB

SE · €403,348

participant

UPPSALA UNIVERSITET

SE · €815,755

participant

MEDBIOINFORMATICS SOLUTIONS SL

ES · €350,000

participant

LIVERPOOL JOHN MOORES UNIVERSITY

UK · €500,000

participant

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU

NL · €929,043

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €339,260

participant

BAYER SAS

FR · €16,805

participant

PNO Innovation

FR · €862,500

participant

L'OREAL SA

FR · €15,000

participant

DANMARKS TEKNISKE UNIVERSITET

DK · €260,348

participant

KAROLINSKA INSTITUTET

SE · €353,200

participant

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

LV · €499,654

participant

UNIVERSITAT KONSTANZ

DE · €1,004,000

participant

TISSUSE GMBH

DE · €650,000

participant

BIOCLAVIS LIMITED

UK · €2,012,231

participant

CHARLES RIVER LABORATOIRIES DEN BOSCH BV

NL · €7,500

participant

SIGNATOPE GMBH

DE · €628,713

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €800,000

participant

UNILEVER U.K. CENTRAL RESOURCES LIMITED

UK · €43,875

participant

INSPHERO AG

CH · €100,000

participant

BASF SE

DE · €626,875

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.